Barclays PLC Sera Prognostics, Inc. Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Barclays PLC holds 44,722 shares of SERA stock, worth $197,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,722
Previous 39,450
13.36%
Holding current value
$197,224
Previous $308,000
18.18%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SERA
# of Institutions
69Shares Held
19.9MCall Options Held
120KPut Options Held
0-
Baker Bros. Advisors LP New York, NY5.43MShares$24 Million0.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$13.4 Million0.33% of portfolio
-
Interwest Venture Management CO2.42MShares$10.7 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$7.28 Million2.79% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$6.22 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $131M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...